🎉 M&A multiples are live!
Check it out!

Pfizer India Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pfizer India and similar public comparables like Vivoryon Therapeutics, Pharming, and Armata Pharmaceuticals.

Pfizer India Overview

About Pfizer India

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.


Founded

1950

HQ

India
Employees

1.6K+

Website

pfizerltd.co.in

Financials

LTM Revenue $267M

LTM EBITDA $88.9M

EV

$2.4B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Pfizer India Financials

As of September 2025, Pfizer India reported last 12-month revenue of $267M and EBITDA of $88.9M.

In the same period, Pfizer India generated $172M in LTM gross profit and $77.3M in net income.

See Pfizer India valuation multiples based on analyst estimates

Pfizer India P&L

In the most recent fiscal year, Pfizer India reported revenue of $257M and EBITDA of $122M.

Pfizer India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Pfizer India valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $267M XXX $257M XXX XXX XXX
Gross Profit $172M XXX $166M XXX XXX XXX
Gross Margin 64% XXX 64% XXX XXX XXX
EBITDA $88.9M XXX $122M XXX XXX XXX
EBITDA Margin 33% XXX 48% XXX XXX XXX
EBIT $92.9M XXX $76.8M XXX XXX XXX
EBIT Margin 35% XXX 30% XXX XXX XXX
Net Profit $77.3M XXX $86.6M XXX XXX XXX
Net Margin 29% XXX 34% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Pfizer India Stock Performance

Pfizer India has current market cap of INR 243B (or $2.7B), and EV of INR 217B (or $2.4B).

Market Cap Evolution

Pfizer India Stock Data

As of October 17, 2025, Pfizer India's stock price is INR 5322 (or $60).

See Pfizer India trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.4B $2.7B XXX XXX XXX XXX $1.69

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Pfizer India Valuation Multiples

Pfizer India's trades at 9.6x EV/Revenue multiple, and 21.3x EV/EBITDA.

See valuation multiples for Pfizer India and 15K+ public comps

Pfizer India Financial Valuation Multiples

As of October 17, 2025, Pfizer India has market cap of $2.7B and EV of $2.4B.

Equity research analysts estimate Pfizer India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Pfizer India has a P/E ratio of 35.5x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $2.7B XXX $2.7B XXX XXX XXX
EV (current) $2.4B XXX $2.4B XXX XXX XXX
EV/Revenue 9.1x XXX 9.6x XXX XXX XXX
EV/EBITDA 27.5x XXX 21.3x XXX XXX XXX
EV/EBIT 26.3x XXX 33.1x XXX XXX XXX
EV/Gross Profit 14.2x XXX n/a XXX XXX XXX
P/E 35.5x XXX 34.1x XXX XXX XXX
EV/FCF 29.6x XXX 40.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Pfizer India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Pfizer India Margins & Growth Rates

Pfizer India's last 12 month revenue growth is 7%

Pfizer India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Pfizer India's rule of 40 is 52% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pfizer India's rule of X is 51% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Pfizer India and other 15K+ public comps

Pfizer India Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 7% XXX 7% XXX XXX XXX
EBITDA Margin 33% XXX 45% XXX XXX XXX
EBITDA Growth 11% XXX -7% XXX XXX XXX
Rule of 40 52% XXX 52% XXX XXX XXX
Bessemer Rule of X XXX XXX 51% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 5% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 34% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Pfizer India Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Pfizer India M&A and Investment Activity

Pfizer India acquired  XXX companies to date.

Last acquisition by Pfizer India was  XXXXXXXX, XXXXX XXXXX XXXXXX . Pfizer India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Pfizer India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Pfizer India

When was Pfizer India founded? Pfizer India was founded in 1950.
Where is Pfizer India headquartered? Pfizer India is headquartered in India.
How many employees does Pfizer India have? As of today, Pfizer India has 1.6K+ employees.
Is Pfizer India publicy listed? Yes, Pfizer India is a public company listed on NSE.
What is the stock symbol of Pfizer India? Pfizer India trades under PFIZER ticker.
When did Pfizer India go public? Pfizer India went public in 1999.
Who are competitors of Pfizer India? Similar companies to Pfizer India include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Pfizer India? Pfizer India's current market cap is $2.7B
What is the current revenue of Pfizer India? Pfizer India's last 12 months revenue is $267M.
What is the current revenue growth of Pfizer India? Pfizer India revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Pfizer India? Current revenue multiple of Pfizer India is 9.1x.
Is Pfizer India profitable? Yes, Pfizer India is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Pfizer India? Pfizer India's last 12 months EBITDA is $88.9M.
What is Pfizer India's EBITDA margin? Pfizer India's last 12 months EBITDA margin is 33%.
What is the current EV/EBITDA multiple of Pfizer India? Current EBITDA multiple of Pfizer India is 27.5x.
What is the current FCF of Pfizer India? Pfizer India's last 12 months FCF is $82.5M.
What is Pfizer India's FCF margin? Pfizer India's last 12 months FCF margin is 31%.
What is the current EV/FCF multiple of Pfizer India? Current FCF multiple of Pfizer India is 29.6x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.